Donna S Neuberg

Donna S Neuberg

UNVERIFIED PROFILE

Are you Donna S Neuberg?   Register this Author

Register author
Donna S Neuberg

Donna S Neuberg

Publications by authors named "Donna S Neuberg"

Are you Donna S Neuberg?   Register this Author

100Publications

3485Reads

38Profile Views

Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias.

Cancer Cell 2019 Apr;35(4):664-676.e7

Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02445, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2019.03.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541931PMC
April 2019

Postoperative bridging anticoagulation and left ventricular assist system thrombosis.

J Thromb Thrombolysis 2019 Jan;47(1):57-66

Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11239-018-1746-7DOI Listing
January 2019

Reply to Z. Wu et al.

J Clin Oncol 2018 09 30;36(25):2657. Epub 2018 May 30.

Donna S. Neuberg, Dana-Farber Cancer Institute; and Harvard T.H. Chan School of Public Health, Boston, MA; Scott J. Rodig, Brigham and Women's Hospital, Boston, MA; and Margaret A. Shipp, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.9826
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.9826DOI Listing
September 2018

The Benefits of TRTHing along.

Hemasphere 2018 Aug 27;2(4):e138. Epub 2018 Jul 27.

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HS9.0000000000000138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746002PMC
August 2018

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.

J Clin Oncol 2018 04 2;36(10):942-950. Epub 2018 Feb 2.

Margaretha G.M. Roemer, Robert A. Redd, Fathima Zumla Cader, Christine J. Pak, Sara Abdelrahman, Jing Ouyang, Philippe Armand, Donna S. Neuberg, and Margaret A. Shipp, Dana-Farber Cancer Institute; Geraldine S. Pinkus, Azra H. Ligon, and Scott J. Rodig, Brigham and Women's Hospital, Boston, MA; Margaretha G.M. Roemer, VU University Medical Center; Jan Paul De Boer, Antoni van Leeuwenhoek Hospital, Lunenburg Phase I/II Consortium, Amsterdam, the Netherlands; Stephanie Sasse, University Hospital of Cologne, Cologne, Germany; Anas Younes, Memorial Sloan Kettering Cancer Center, New York, NY; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Armando Santoro, Humanitas University, Rozzano, Milan; Pier Luigi Zinzani, University of Bologna, Bologna, Italy; John Timmerman, University of California, Los Angeles Medical Center, Los Angeles, CA; Graham P. Collins, Churchill Hospital, Oxford, United Kingdom; Radhakrishnan Ramchandren, Barbara Ann Karmanos Cancer Institute, Detroit, MI; Jonathon B. Cohen, Emory University, Atlanta, GA; John Kuruvilla, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Kerry J. Savage, British Columbia Cancer Agency Center for Lymphoid Cancer, Vancouver, British Columbia, Canada; Marek Trneny, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic; Stephen Ansell, Mayo Clinic, Rochester, MN; and Kazunobu Kato, Benedetto Farsaci, and Anne Sumbul, Bristol-Myers Squibb, Princeton, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.3994DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877802PMC
April 2018

Statistics Everywhere.

Authors:
Donna S Neuberg

Hemasphere 2018 Jan-Feb;2(1):e30. Epub 2018 Feb 2.

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HS9.0000000000000030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745945PMC
February 2018

Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage.

Proc Natl Acad Sci U S A 2016 11 14;113(48):E7701-E7709. Epub 2016 Nov 14.

Department of Genetics, Harvard Medical School, Boston, MA 02215;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1611673113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137757PMC
November 2016

Biophysical determinants for cellular uptake of hydrocarbon-stapled peptide helices.

Nat Chem Biol 2016 10 22;12(10):845-52. Epub 2016 Aug 22.

Department of Pediatric Oncology, Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nchembio.2153
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055751PMC
http://dx.doi.org/10.1038/nchembio.2153DOI Listing
October 2016

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.

J Clin Oncol 2016 08 11;34(23):2690-7. Epub 2016 Apr 11.

Margaretha G.M. Roemer, Robert A. Redd, Heather Homer, Courtney F. Connelly, Gordon J. Freeman, Philippe Armand, Bjoern Chapuy, Donna S. Neuberg, and Margaret A. Shipp, Dana-Farber Cancer Institute; Azra H. Ligon, Heather H. Sun, and Scott J. Rodig, Brigham and Women's Hospital, Boston, MA; Margaretha G.M. Roemer and Daphne de Jong, VU University Medical Center, Amsterdam, the Netherlands; and Ranjana H. Advani, Yasodha Natkunam, Sarah E. Daadi, and Richard T. Hoppe, Stanford University Medical Center, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.4482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019753PMC
August 2016

Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000-2010).

Pediatr Blood Cancer 2016 Jun 23;63(6):1012-8. Epub 2016 Feb 23.

Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25928DOI Listing
June 2016

MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice.

Am J Clin Pathol 2016 Feb 1;145(2):166-79. Epub 2016 Feb 1.

From the Department of Pathology, Brigham and Women's Hospital, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcp/aqv028DOI Listing
February 2016

Polymorphisms in Genes Related to Oxidative Stress Are Associated With Inferior Cognitive Function After Therapy for Childhood Acute Lymphoblastic Leukemia.

J Clin Oncol 2015 Jul 18;33(19):2205-11. Epub 2015 May 18.

Peter D. Cole, Veena Vijayanathan, Albert Einstein College of Medicine, Bronx, NY; Yaron Finkelstein, Hospital for Sick Children, University of Toronto, Toronto; Philippe Robaey, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada; Kristen E. Stevenson, Traci M. Blonquist, Donna S. Neuberg, Dana-Farber Cancer Institute (DFCI); Lewis B. Silverman, Stephen E. Sallan, DFCI, Boston Children's Hospital, Harvard Medical School; and Deborah P. Waber, DFCI, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/05/18/JCO.2014.59
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.0273
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.0273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477790PMC
July 2015

Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea.

Blood 2015 Jun;125(23):3668-9

Division of Hematology, Brigham and Women's Hospital, Boston, MA Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2015-03-63
Publisher Site
http://dx.doi.org/10.1182/blood-2015-03-635391DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458806PMC
June 2015

Loss of function tp53 mutations do not accelerate the onset of myc-induced T-cell acute lymphoblastic leukaemia in the zebrafish.

Br J Haematol 2014 Jul 2;166(1):84-90. Epub 2014 Apr 2.

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12851DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234197PMC
July 2014

Landscape of genomic alterations in cervical carcinomas.

Nature 2014 Feb 25;506(7488):371-5. Epub 2013 Dec 25.

1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA [3] Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA [4].

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature12881DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161954PMC
February 2014

Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: results of a phase 1 study.

Leuk Lymphoma 2013 Sep 30;54(9):1915-20. Epub 2013 Jan 30.

Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.763397DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595907PMC
September 2013

Trends in all-cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysis.

Cancer 2013 Jul 26;119(14):2620-9. Epub 2013 Apr 26.

Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28106DOI Listing
July 2013

Reprise: gemtuzumab ozogamicin for older patients with acute myeloid leukemia.

Authors:
Donna S Neuberg

J Clin Oncol 2012 Nov 17;30(32):3905-6. Epub 2012 Sep 17.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.43.6592DOI Listing
November 2012

Zebrafish mast cells possess an FcɛRI-like receptor and participate in innate and adaptive immune responses.

Dev Comp Immunol 2011 Jan 19;35(1):125-34. Epub 2010 Sep 19.

IWK Health Centre, Dalhousie University, PO Box 9700, 5850/5980 University Avenue, Halifax, NS B3K 6R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dci.2010.09.001DOI Listing
January 2011

Timing of postpartum enoxaparin administration and severe postpartum hemorrhage.

Blood Coagul Fibrinolysis 2008 Jan;19(1):55-9

Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MBC.0b013e3282f185ddDOI Listing
January 2008